$64.71
0.160.25%
At close: -
$64.71
0.000.00%
After Hours: 4:32 PM EDT
Comments
Loading...
Arcellx Analyst Ratings and Price Targets | NASDAQ:ACLX | Benzinga
Arcellx Inc has a consensus price target of $99.79 based on the ratings of 18 analysts. The high is $136 issued by Truist Securities on November 12, 2024. The low is $39 issued by SVB Leerink on March 30, 2023. The 3 most-recent analyst ratings were released by UBS, HC Wainwright & Co., and Needham on December 10, 2024, respectively. With an average price target of $111.33 between UBS, HC Wainwright & Co., and Needham, there's an implied 72.05% upside for Arcellx Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
HC Wainwright & Co.
Needham
Truist Securities
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Arcellx
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 12/10/2024 | Buy Now | 76.17% | UBS | Ashwani Verma44% | $106 → $114 | Maintains | Buy | Get Alert |
| 12/10/2024 | Buy Now | 77.72% | HC Wainwright & Co. | Emily Bodnar39% | $115 → $115 | Reiterates | Buy → Buy | Get Alert |
| 12/10/2024 | Buy Now | 62.26% | Needham | Gil Blum51% | $105 → $105 | Reiterates | Buy → Buy | Get Alert |
| 12/09/2024 | Buy Now | 62.26% | Needham | Gil Blum51% | $105 → $105 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | 110.17% | Truist Securities | Asthika Goonewardene41% | $87 → $136 | Maintains | Buy | Get Alert |
| 11/08/2024 | Buy Now | 77.72% | HC Wainwright & Co. | Emily Bodnar39% | $95 → $115 | Maintains | Buy | Get Alert |
| 11/08/2024 | Buy Now | 77.72% | Piper Sandler | Biren Amin41% | $91 → $115 | Maintains | Overweight | Get Alert |
| 11/08/2024 | Buy Now | 62.26% | Needham | Gil Blum51% | $96 → $105 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 63.81% | Morgan Stanley | Judah Frommer66% | $81 → $106 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 54.54% | B of A Securities | Jason Gerberry59% | $84 → $100 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 63.81% | Baird | Jack Allen 35% | $77 → $106 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | 46.81% | HC Wainwright & Co. | Emily Bodnar39% | $80 → $95 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 48.35% | Needham | Gil Blum51% | $96 → $96 | Reiterates | Buy → Buy | Get Alert |
| 10/31/2024 | Buy Now | 48.35% | Needham | Gil Blum51% | $96 → $96 | Reiterates | Buy → Buy | Get Alert |
| 10/22/2024 | Buy Now | 48.35% | Needham | Gil Blum51% | $81 → $96 | Maintains | Buy | Get Alert |
| 10/18/2024 | Buy Now | 88.53% | Stifel | Benjamin Burnett45% | $83 → $122 | Maintains | Buy | Get Alert |
| 10/17/2024 | Buy Now | 77.72% | Canaccord Genuity | John Newman45% | $85 → $115 | Maintains | Buy | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Josh Schimmer53% | — | Reiterates | → Overweight | Get Alert |
| 09/03/2024 | Buy Now | — | Cantor Fitzgerald | Rick Bienkowski27% | — | Initiates | → Overweight | Get Alert |
| 08/09/2024 | Buy Now | 25.17% | Needham | Gil Blum51% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
| 07/22/2024 | Buy Now | 31.36% | Canaccord Genuity | John Newman45% | $85 → $85 | Maintains | Buy | Get Alert |
| 06/18/2024 | Buy Now | 34.45% | Truist Securities | Asthika Goonewardene41% | $87 → $87 | Maintains | Buy | Get Alert |
| 05/31/2024 | Buy Now | 8.17% | Piper Sandler | Biren Amin41% | → $70 | Initiates | → Overweight | Get Alert |
| 05/15/2024 | Buy Now | 28.26% | Stifel | Benjamin Burnett45% | $82 → $83 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | 31.36% | Evercore ISI Group | Cory Kasimov70% | → $85 | Initiates | → Outperform | Get Alert |
| 05/13/2024 | Buy Now | 23.63% | HC Wainwright & Co. | Emily Bodnar39% | $82 → $80 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | 25.17% | Needham | Gil Blum51% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 25.17% | Needham | Gil Blum51% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
| 04/11/2024 | Buy Now | 25.17% | Needham | Gil Blum51% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | Buy Now | 25.17% | Needham | Gil Blum51% | $72 → $81 | Maintains | Buy | Get Alert |
| 03/14/2024 | Buy Now | 26.72% | Stifel | Benjamin Burnett45% | → $82 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | Buy Now | 25.17% | Morgan Stanley | Judah Frommer66% | → $81 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | 34.45% | Truist Securities | Asthika Goonewardene41% | $57 → $87 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | 26.72% | HC Wainwright & Co. | Emily Bodnar39% | $60 → $82 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | 31.36% | Canaccord Genuity | John Newman45% | $66 → $85 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | 12.81% | Barclays | Carter Gould59% | $62 → $73 | Maintains | Overweight | Get Alert |
| 02/29/2024 | Buy Now | 11.27% | Needham | Gil Blum51% | $71 → $72 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | 18.99% | Baird | Jack Allen 35% | $63 → $77 | Maintains | Outperform | Get Alert |
| 01/04/2024 | Buy Now | 9.72% | Needham | Gil Blum51% | $65 → $71 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | 1.99% | Scotiabank | George Farmer43% | → $66 | Initiates | → Sector Outperform | Get Alert |
| 12/12/2023 | Buy Now | 0.45% | Needham | Gil Blum51% | $65 → $65 | Reiterates | Buy → Buy | Get Alert |
| 12/11/2023 | Buy Now | 0.45% | Needham | Gil Blum51% | $60 → $65 | Maintains | Buy | Get Alert |
| 11/16/2023 | Buy Now | 1.99% | Canaccord Genuity | John Newman45% | $49 → $66 | Maintains | Buy | Get Alert |
| 11/16/2023 | Buy Now | -4.19% | Barclays | Carter Gould59% | $49 → $62 | Maintains | Overweight | Get Alert |
| 11/15/2023 | Buy Now | -7.28% | HC Wainwright & Co. | Emily Bodnar39% | $50 → $60 | Maintains | Buy | Get Alert |
| 11/15/2023 | Buy Now | -7.28% | Needham | Gil Blum51% | $51 → $60 | Maintains | Buy | Get Alert |
| 10/30/2023 | Buy Now | — | TD Cowen | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 10/17/2023 | Buy Now | -19.64% | UBS | Ashwani Verma44% | → $52 | Initiates | → Buy | Get Alert |
| 08/15/2023 | Buy Now | -19.64% | Baird | Jack Allen 35% | $40 → $52 | Maintains | Outperform | Get Alert |
| 08/15/2023 | Buy Now | -19.64% | Stifel | Benjamin Burnett45% | $54 → $52 | Maintains | Buy | Get Alert |
| 08/15/2023 | Buy Now | -21.19% | Needham | Gil Blum51% | $51 → $51 | Reinstates | Buy → Buy | Get Alert |
| 08/15/2023 | Buy Now | -22.73% | HC Wainwright & Co. | Emily Bodnar39% | $49 → $50 | Maintains | Buy | Get Alert |
| 06/23/2023 | Buy Now | -21.19% | Needham | Gil Blum51% | → $51 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2023 | Buy Now | -24.28% | Canaccord Genuity | John Newman45% | $49 → $49 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2023 | Buy Now | -24.28% | HC Wainwright & Co. | Emily Bodnar39% | → $49 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | — | Guggenheim | Kelsey Goodwin30% | — | Maintains | Buy | Get Alert |
| 06/20/2023 | Buy Now | -24.28% | HC Wainwright & Co. | Emily Bodnar39% | → $49 | Reiterates | → Buy | Get Alert |
| 06/20/2023 | Buy Now | -11.91% | Truist Securities | Asthika Goonewardene41% | $60 → $57 | Maintains | Buy | Get Alert |
| 06/20/2023 | Buy Now | -21.19% | Needham | Gil Blum51% | → $51 | Reiterates | Buy → Buy | Get Alert |
| 05/18/2023 | Buy Now | -7.28% | Truist Securities | Asthika Goonewardene41% | → $60 | Initiates | → Buy | Get Alert |
| 05/10/2023 | Buy Now | -22.73% | B of A Securities | Jason Gerberry59% | $39 → $50 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | -24.28% | HC Wainwright & Co. | Emily Bodnar39% | $40 → $49 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | -21.19% | Needham | Gil Blum51% | $35 → $51 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | -24.28% | Barclays | Carter Gould59% | $38 → $49 | Maintains | Overweight | Get Alert |
| 04/26/2023 | Buy Now | -24.28% | Canaccord Genuity | John Newman45% | $40 → $49 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | -10.37% | Guggenheim | Kelsey Goodwin30% | $45 → $58 | Maintains | Buy | Get Alert |
| 04/19/2023 | Buy Now | -38.19% | Canaccord Genuity | John Newman45% | $34 → $40 | Maintains | Buy | Get Alert |
| 04/14/2023 | Buy Now | -39.73% | Baird | Jack Allen 35% | → $39 | Initiates | → Outperform | Get Alert |
| 04/13/2023 | Buy Now | -39.73% | Baird | Jack Allen 35% | → $39 | Initiates | → Outperform | Get Alert |
| 03/30/2023 | Buy Now | -45.91% | Needham | Gil Blum51% | → $35 | Reiterates | → Buy | Get Alert |
| 03/30/2023 | Buy Now | -39.73% | SVB Leerink | Daina Graybosch43% | $35 → $39 | Maintains | Outperform | Get Alert |
| 03/30/2023 | Buy Now | -38.19% | HC Wainwright & Co. | Emily Bodnar39% | $42 → $40 | Maintains | Buy | Get Alert |
| 03/14/2023 | Buy Now | -33.55% | Stifel | Benjamin Burnett45% | → $43 | Initiates | → Buy | Get Alert |
| 02/13/2023 | Buy Now | -35.1% | HC Wainwright & Co. | Emily Bodnar39% | → $42 | Initiates | → Buy | Get Alert |
| 12/13/2022 | Buy Now | -42.82% | B of A Securities | Jason Gerberry59% | → $37 | Reinstates | → Buy | Get Alert |
| 12/12/2022 | Buy Now | -45.91% | Needham | Gil Blum51% | $31 → $35 | Maintains | Buy | Get Alert |
| 12/12/2022 | Buy Now | -41.28% | Barclays | Carter Gould59% | $25 → $38 | Maintains | Overweight | Get Alert |
| 10/31/2022 | Buy Now | -44.37% | Guggenheim | Kelsey Goodwin30% | → $36 | Initiates | → Buy | Get Alert |
| 10/27/2022 | Buy Now | -52.09% | Needham | Gil Blum51% | → $31 | Initiates | → Buy | Get Alert |
| 07/20/2022 | Buy Now | -50.55% | Canaccord Genuity | John Newman45% | → $32 | Initiates | → Buy | Get Alert |
| 06/23/2022 | Buy Now | -41.28% | SVB Leerink | Daina Graybosch43% | $47 → $38 | Maintains | Outperform | Get Alert |
| 05/13/2022 | Buy Now | -27.37% | SVB Leerink | Daina Graybosch43% | $44 → $47 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Arcellx (ACLX) stock?
The latest price target for Arcellx (NASDAQ:ACLX) was reported by UBS on December 10, 2024. The analyst firm set a price target for $114.00 expecting ACLX to rise to within 12 months (a possible 76.17% upside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Arcellx (ACLX)?
The latest analyst rating for Arcellx (NASDAQ:ACLX) was provided by UBS, and Arcellx maintained their buy rating.
When was the last upgrade for Arcellx (ACLX)?
There is no last upgrade for Arcellx
When was the last downgrade for Arcellx (ACLX)?
There is no last downgrade for Arcellx.
When is the next analyst rating going to be posted or updated for Arcellx (ACLX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arcellx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arcellx was filed on December 10, 2024 so you should expect the next rating to be made available sometime around December 10, 2025.
Is the Analyst Rating Arcellx (ACLX) correct?
While ratings are subjective and will change, the latest Arcellx (ACLX) rating was a maintained with a price target of $106.00 to $114.00. The current price Arcellx (ACLX) is trading at is $64.71, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
